Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’
The product will be available under the brand name ‘Ledisof’ in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
EU’s ban of 700 pharma products will impact Indian pharma export by $1 bn
Indian govt defers FTA talks with EU
New drug capsule shells offer new choice: veg or non-veg
Expert panel to meet tomorrow to decide on gelatin versus cellulose
Veg or non-veg? Not too far in the future, the person asking…